跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Dolfenal - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Dolfenal
Approved
STANDARD
Dolfenal
Amherst Laboratories, Inc.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
3ae9fcdec263bdbf
Company
Amherst Laboratories, Inc.
Type
Standard
Approval Details
Approval Id
3ae9fcdec263bdbf
Drug Approval Philippines Name
Dolfenal
Product Name
Dolfenal
Registration Number
DRP-8716
Brand Name
Dolfenal
Generic Name
Mefenamic Acid
Dosage Form
Film-Coated Tablet
Dosage Strength
250 mg
Manufacturer
Amherst Laboratories, Inc.
Issuance Date
29 March 2022
Expiry Date
25 May 2027
Pharmacologic Category
Anti-Inflammatory and Anti-Rheumatic Products, Non-Steroids (Fenamates)
Classification
Over-the-Counter (OTC)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
3ae9fcdec263bdbf
Type
Standard
Back to Philippines FDA Approvals